Myriad Genetics Highlights Data Showing Broad Clinical Utility of Precise MRD Assay at 2026 ASCO Annual Meeting
Go back to Myriad Genetics Highlights Data Showing Broad Clinical Utility of Precise MRD Assay at 2026 ASCO Annual Meeting| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 4.50 -0.04 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.54 | 52 Week High | $45.34 | |||
| Open | $4.54 | 52 Week Low | $15.92 | |||
| Day High | $4.62 | P/E | 1.93 | |||
| Day Low | $4.42 | EPS | $2.33 | |||
| Volume | 1,271,242 | |||||
